![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » MEDTRONIC LAUNCHES IMPLANTABLE CARDIAC DEVICES WITH WIRELESS TELEMETRY IN EUROPE
MEDTRONIC LAUNCHES IMPLANTABLE CARDIAC DEVICES WITH WIRELESS TELEMETRY IN EUROPE
June 19, 2006
Medtronic, Inc., has announced European approval and market availability of its Concerto and Virtuoso line of implantable cardiac defibrillators. These are Medtronic's first cardiac rhythm
disease management devices with wireless telemetry, enabling communication remotely
between the implanted device and programmers in a clinician's office and at implant,
or between the device and a patient home monitor.
Medical
Technology Business Europe
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct